There is progressive evolution in the use of inhalable drug delivery systems (DDSs) for lung
cancer therapy. The inhalation route offers many advantages, being non-invasive method of …

In the past decade, there has been a shift in research, clinical development, and commercial
activity to exploit the many physiological roles of RNA for use in medicine. With the rapid …

RNA interference (RNAi), also known as gene silencing, is a biological process that
prevents gene expression in certain diseases such as cancer. It can be used to improve the …

The low yield of extracellular vesicle (EV) secretion is a major obstacle for mass production
and limits their potential for clinical applications as a drug delivery platform. Here, we mass …

Gold nanoparticles (AuNPs) possess unique size-dependent optical, electronic, and
chemical properties, making them auspicious and tunable nanoscale building blocks for …

Highlights•Exogenous application of dsRNA can induce antiviral silencing in plants.•Naked
dsRNA on leaves affords virus protection only up to 5 days postspray.•Nanoparticle …

An overview of the application of natural and synthetic, non-viral vectors for oligonucleotide
delivery into the lung is presented in this review, with a special focus on lung cancer. Due to …

Clustered regularly interspaced short palindromic repeats‐associated protein
(CRISPR/Cas9), an adaptive microbial immune system, has been exploited as a robust …

Lung cancer is managed using conventional therapies, including chemotherapy, radiation
therapy, or a combination of both. Each of these therapies has its own limitations, such as …

The very dynamic growth of nanotechnology, nanomaterials (sized 1–100 nm) and their
medical applications over the past 10 years has promised to add a new impetus to the …